Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant
- PMID: 26517408
- PMCID: PMC4851904
- DOI: 10.1002/hep.28317
Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant
Conflict of interest statement
Potential conflict of interest: Nothing to report.
Comment in
-
Reply.Hepatology. 2016 Jul;64(1):310-1. doi: 10.1002/hep.28314. Epub 2015 Dec 23. Hepatology. 2016. PMID: 26517017 No abstract available.
Comment on
-
Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.Hepatology. 2015 May;61(5):1547-54. doi: 10.1002/hep.27368. Epub 2015 Mar 23. Hepatology. 2015. PMID: 25125077
References
-
- Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547–1554. - PubMed
-
- Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 1990;11:74–80. - PubMed
-
- Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44:874–880. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
